Ignite Creation Date:
2024-05-05 @ 4:39 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00284089
Status:
COMPLETED
Last Update Posted:
2011-02-24
First Post:
2006-01-30
Brief Title:
Safety and Efficacy of Ranibizumab in Japanese Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration
Sponsor:
Novartis
Organization:
Novartis
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Subfoveal Choroidal NeovascularizationCNV Secondary to Age-related Macular Degeneration AMD |
Keywords:
| Name | View |
|---|---|
| Subfoveal CNV AMD ranibizumab | View |